<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6901432/results/search/country/results.xml">
  <result pre="am MainGermany Edited by: Michael Nevels, University of St Andrews," exact="United Kingdom" post="Reviewed by: Junji Xing, Houston Methodist Research Institute, United"/>
  <result pre="United Kingdom Reviewed by: Junji Xing, Houston Methodist Research Institute," exact="United States;" post="Oliver H. Krämer, Johannes Gutenberg University Mainz, Germany *Correspondence:"/>
  <result pre="Institute, United States; Oliver H. Krämer, Johannes Gutenberg University Mainz," exact="Germany" post="*Correspondence: Jindrich Cinatl Jr., Cinatl@em.uni-frankfurt.de This article was submitted"/>
  <result pre="Vignuzzi, 2014; Koh and Liang, 2014; Galli et al., 2018;" exact="Jordan" post="et al., 2018; Keppeke et al., 2019). Our findings"/>
  <result pre="Germany), omeprazole from AstraZeneca (Wedel, Germany), ribavirin from Valeant Pharmaceuticals" exact="Germany" post="GmbH (Eschborn, Germany), and pantoprazole, rabeprazole, lansoprazole, and dexlansoprazole"/>
 </snippets>
</snippetsTree>
